Insider · CIK 0001943108
Matthew Charles McMurdo
Files at TTNP (TITAN PHARMACEUTICALS INC), CFOR (OPGEN INC), FIEE (MINIM, INC.). First filing -, latest -.
In brief
Matthew Charles McMurdo files SEC Form 4 as director at TTNP (TITAN PHARMACEUTICALS INC), and also at CFOR (OPGEN INC), FIEE (MINIM, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Charles McMurdo has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | FIEE MINIM, INC. | AGrant or award Common Stock | +159,364 | - | - | 184,364 | Oct 1, 2024 |
| Apr 11, 2024 | CFOR OPGEN INC | AGrant or award Common Stock | +100,000 | - | - | 100,000 | Apr 12, 2024 |
| Jan 22, 2024 | FIEE MINIM, INC. | AGrant or award Common Stock | +25,000 | - | - | 25,000 | Jan 24, 2024 |
| Oct 25, 2023 | TTNP TITAN PHARMACEUTICALS INC | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
Questions about Matthew Charles McMurdo
Answered from the filings on this page, as of the latest one.
Is Matthew Charles McMurdo buying or selling?
Matthew Charles McMurdo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Charles McMurdo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Charles McMurdo has 0.
Where does Matthew Charles McMurdo file Form 4?
Matthew Charles McMurdo has filed Form 4 at TTNP (TITAN PHARMACEUTICALS INC); CFOR (OPGEN INC); FIEE (MINIM, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.